Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Glaxosmithkline Pharmaceuticals Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 28 September 2026, 8:35 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price2,896₹ per share
Reported P/E46.6Times
Book value per share134₹ per share
Reported ROCE61.4 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 28 September 2026, 8:35 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap49,047 Cr.
Current Price2,896
High / Low3,121/2,088
Stock P/E46.6
Book Value134
Dividend Yield1.97 %
ROCE61.4 %
ROE45.6 %
Face Value10.0

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Glaxosmithkline Pharmaceuticals Ltd 49,047 Cr. 2,896 3,121/2,08846.6 1341.97 %61.4 %45.6 % 10.0
Ipca Laboratories Ltd 48,726 Cr. 1,919 2,039/1,25235.5 3180.31 %17.0 %15.7 % 1.00
Gland Pharma Ltd 47,817 Cr. 2,896 3,042/1,57433.8 6560.69 %17.4 %12.8 % 1.00
Ajanta Pharma Ltd 44,039 Cr. 3,525 3,797/2,33038.8 3620.91 %34.5 %27.1 % 2.00
Abbott India Ltd 56,863 Cr. 26,740 30,655/25,13535.2 2,2471.96 %44.8 %34.4 % 10.0
Industry Average17,774.69 Cr1,258.9655.96211.600.38%26.16%16.59%6.06

All Competitor Stocks of Glaxosmithkline Pharmaceuticals Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 9178027877629578059308151,0119499748059801,041995938
Expenses 660574618618668587673584689658641554644670644643
Operating Profit 257229170144289218257231322292333251336371351296
OPM % 28%29%22%19%30%27%28%28%32%31%34%31%34%36%35%31%
Other Income 2212385428-13532363935414436503644
Interest 0010001000101111
Depreciation 16161716181718161719151617201316
Profit before tax 26222419018129965271249344308359279354400373322
Tax % 26%27%30%27%27%30%28%27%27%25%27%27%27%26%26%26%
Net Profit 19316513313221846194182252230263205257296278237
EPS in Rs 11.429.717.887.8112.842.7011.4810.7614.9113.5715.5212.1015.2017.4516.4014.00

Last Updated: September 27, 2026, 2:47 am

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Mar 2015 covers 15 months. Values for periods of different lengths are not directly comparable.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Mar 2015 covers 15 months. Values for periods of different lengths are not directly comparable.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 27, 2026, 2:47 am

MetricDec 2013Mar 2015 (15 months)Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 2,5633,3052,8382,9082,8713,1283,2242,9263,2783,2523,4543,7493,8223,955
Expenses 2,0342,6722,3602,4892,3632,5272,5672,3272,5162,4472,5452,5702,5122,601
Operating Profit 5286334784205086016575987628049091,1791,3091,354
OPM % 21%19%17%14%18%19%20%20%23%25%26%31%34%34%
Other Income 20314912511970131-26291,401103-21149166166
Interest 00000164222133
Depreciation 2025252738498379686670676667
Profit before tax 7117565785115406833065252,0938398161,2601,4061,449
Tax % 32%37%35%34%35%35%70%32%19%27%28%26%26%
Net Profit 482476376337351445933581,6956115909281,0361,068
EPS in Rs 28.4328.1222.2019.8820.7026.295.5021.14100.0436.0534.8354.7561.1563.05
Dividend Payout % 88%111%113%75%85%76%727%142%90%89%92%99%93%

YoY Net Profit Growth

Year2016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)-10.37%4.15%26.78%-79.10%284.95%373.46%-63.95%-3.44%57.29%11.64%
Change in YoY Net Profit Growth (%)0.00%14.53%22.63%-105.88%364.05%88.52%-437.42%60.52%60.73%-45.65%

Glaxosmithkline Pharmaceuticals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2016-2017 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:1%
5 Years:3%
3 Years:5%
TTM:7%
Compounded Profit Growth
10 Years:6%
5 Years:35%
3 Years:-20%
TTM:23%
Stock Price CAGR
10 Years:6%
5 Years:13%
3 Years:26%
1 Year:1%
Return on Equity
10 Years:30%
5 Years:45%
3 Years:36%
Last Year:47%

Last Updated: September 5, 2025, 4:50 am

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: June 30, 2026, 2:00 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 85858585169169169169169169169169
Reserves 1,7442,0991,9221,9731,9701,6511,3092,4941,5721,6081,7822,098
Borrowings 322110352016191033
Other Liabilities 1,3848699951,8891,7711,3151,6021,9501,5701,7602,1472,023
Total Liabilities 3,2163,0553,0043,9473,9113,1363,1154,6333,3273,5574,1084,324
Fixed Assets 123204258325432758387331330321284281
CWIP 1152686059231,003120133020141433
Investments 06000003665188131,1181,392
Other Assets 2,9772,5772,1402,7002,4772,2572,7153,9072,4582,4082,6922,618
Total Assets 3,2163,0553,0043,9473,9113,1363,1154,6333,3273,5574,1084,324
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 3381392344734094905788114845821,290903
Cash from Investing Activity + 180499301-104-153-57418-4068089-46397
Cash from Financing Activity + -497-638-511-307-358-428-696-524-1,543-562-769-737
Net Cash Flow 21-02462-1026300-119-25129475563
Free Cash Flow 175-69-246391663365362,3714515731,273870
CFO/OP 93%72%94%133%101%103%121%122%93%92%116%93%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow175.00-69.00-24.00639.00166.00336.00536.002,371.00451.00573.001,273.00870.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthDec 2013Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 141116211914112723222328
Inventory Days 10991156111147131135159144131144126
Days Payable 90749773149109100135156122171186
Cash Conversion Cycle 33277560173646501131-4-31
Working Capital Days -45-48267-90-72-38-39-94-57-64-99
ROCE %34%42%29%22%26%31%33%38%37%36%51%63%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%
FIIs 2.50%2.93%3.48%4.02%4.36%4.50%4.52%4.89%4.79%4.63%4.62%4.79%
DIIs 10.01%8.64%7.90%7.51%7.34%7.30%7.79%7.71%7.75%7.70%7.68%7.81%
Government 0.01%0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public 12.48%13.42%13.62%13.48%13.30%13.21%12.69%12.41%12.45%12.67%12.69%12.42%
No. of Shareholders 1,15,2681,14,6631,18,9941,18,5151,19,2281,19,6251,21,8851,23,6291,22,9041,22,4601,21,7631,26,087
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
SBI Midcap Fund 1,200,000 1.29 288.19N/AN/AN/A
Kotak Large & Midcap Fund 1,100,000 0.88 264.18N/AN/AN/A
Nippon India Pharma Fund 913,226 2.78 219.32853,9072025-12-08 01:23:056.95%
Nippon India Growth Mid Cap Fund 559,000 0.32 134.25N/AN/AN/A
SBI Dividend Yield Fund 450,000 1.21 108.07N/AN/AN/A
Kotak Flexicap Fund 399,331 0.17 95.9N/AN/AN/A
Bajaj Finserv Flexi Cap Fund 318,621 1.23 76.52290,0802026-02-23 01:13:059.84%
Aditya Birla Sun Life MNC Fund 260,835 1.83 62.64N/AN/AN/A
Bandhan ELSS Tax Saver Fund 255,000 0.87 61.24245,0002026-02-23 01:13:054.08%
Aditya Birla Sun Life Multi-Cap Fund 227,787 0.84 54.71N/AN/AN/A

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 54.5241.1436.0899.2931.35
Diluted EPS (Rs.) 54.7634.8336.05100.0421.14
Cash EPS (Rs.) 58.7038.9439.93104.0625.78
Book Value[Excl.RevalReserv]/Share (Rs.) 115.19104.93102.79157.1987.26
Book Value[Incl.RevalReserv]/Share (Rs.) 115.19104.93102.79157.1987.26
Revenue From Operations / Share (Rs.) 221.32203.87191.95193.50172.70
PBDIT / Share (Rs.) 78.1160.8853.4249.4541.84
PBIT / Share (Rs.) 74.1756.7649.5445.4237.20
PBT / Share (Rs.) 74.3748.1849.3745.9926.80
Net Profit / Share (Rs.) 54.7634.8336.05100.0421.14
NP After MI And SOA / Share (Rs.) 54.9135.0736.41100.0421.14
PBDIT Margin (%) 35.2929.8627.8225.5524.22
PBIT Margin (%) 33.5127.8425.8023.4721.53
PBT Margin (%) 33.6023.6325.7223.7615.51
Net Profit Margin (%) 24.7417.0818.7851.6912.24
NP After MI And SOA Margin (%) 24.8117.2018.9651.6912.24
Return on Networth / Equity (%) 47.6733.4235.4163.6424.22
Return on Capital Employeed (%) 57.0347.3341.9526.2135.80
Return On Assets (%) 22.6416.7018.5336.5711.49
Asset Turnover Ratio (%) 0.971.000.800.830.93
Current Ratio (X) 1.791.841.882.181.63
Quick Ratio (X) 1.541.491.531.871.22
Inventory Turnover Ratio (X) 7.451.110.811.040.89
Dividend Payout Ratio (NP) (%) 80.1291.24247.2129.98189.20
Dividend Payout Ratio (CP) (%) 74.7681.66223.3928.82155.15
Earning Retention Ratio (%) 19.888.76-147.2170.02-89.20
Cash Earning Retention Ratio (%) 25.2418.34-123.3971.18-55.15
Interest Coverage Ratio (X) 1007.30573.35499.36419.65200.69
Interest Coverage Ratio (Post Tax) (X) 703.51408.84336.84185.96131.22
Enterprise Value (Cr.) 47339.6731854.0621275.9725686.8623243.30
EV / Net Operating Revenue (X) 12.639.226.547.847.94
EV / EBITDA (X) 35.7730.8923.5130.6732.80
MarketCap / Net Operating Revenue (X) 13.009.536.908.598.34
Retention Ratios (%) 19.878.75-147.2170.01-89.20
Price / BV (X) 24.9818.5212.8810.5816.51
Price / Net Operating Revenue (X) 13.009.536.908.598.34
EarningsYield 0.010.010.020.060.01
Advertisements
Explore Industry-wise Company financial data